Last reviewed · How we verify
Anti-TNF
Anti-TNF is a Small molecule drug developed by Abu Dhabi Stem Cells Center. It is currently FDA-approved. Also known as: Adalimumab, etanercept, certolizumab, or golimumab, Remicade, Humira, Cimzia.
At a glance
| Generic name | Anti-TNF |
|---|---|
| Also known as | Adalimumab, etanercept, certolizumab, or golimumab, Remicade, Humira, Cimzia |
| Sponsor | Abu Dhabi Stem Cells Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases (PHASE1, PHASE2)
- Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (PHASE3)
- Pro- and Anti-inflammatory Cytokines in PCOS
- Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
- Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis (PHASE3)
- The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy (PHASE2, PHASE3)
- Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule (PHASE2)
- A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-TNF CI brief — competitive landscape report
- Anti-TNF updates RSS · CI watch RSS
- Abu Dhabi Stem Cells Center portfolio CI
Frequently asked questions about Anti-TNF
What is Anti-TNF?
Anti-TNF is a Small molecule drug developed by Abu Dhabi Stem Cells Center.
Who makes Anti-TNF?
Anti-TNF is developed and marketed by Abu Dhabi Stem Cells Center (see full Abu Dhabi Stem Cells Center pipeline at /company/abu-dhabi-stem-cells-center).
Is Anti-TNF also known as anything else?
Anti-TNF is also known as Adalimumab, etanercept, certolizumab, or golimumab, Remicade, Humira, Cimzia.
What development phase is Anti-TNF in?
Anti-TNF is FDA-approved (marketed).
Related
- Manufacturer: Abu Dhabi Stem Cells Center — full pipeline
- Also known as: Adalimumab, etanercept, certolizumab, or golimumab, Remicade, Humira, Cimzia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing